Ashley Fry in Bessemer, Alabama

Home Alabama Bessemer

Ashley Fry has Medical Oncology as her primary medical specialty. Their primary office is: 737 Memorial Dr in Bessemer, Alabama. There is an additional office location, for a total of two, for Ashley Fry that can be viewed further down.

They're a part of the: Birmingham Hematology Oncology Assoc Llc medical group which has around 28 members. You can call their office at 205-481-4511 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Mississippi School Of Medicine and graduated in 2010 (around 14 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ashley M Fry Office Phone and Directions

Ashley Fry
Birmingham Hematology Oncology Assoc Llc
737 Memorial Dr
Bessemer, Alabama 35022
205-481-4511

Patient Ratings
Please rate your experience with Ashley Fry below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 205-481-4511

Enter a starting address:

Healthcare Info for Ashley Fry

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: University Of Mississippi School Of Medicine
Graduation Year: 2010
The Primary Medical Specialty for Ashley Fry is listed as: Medical Oncology
Approximate Years of Experience: 14
PAC (PECOS ID)#: 5092952879
NPI #: 1184941460
NPI Created On: 04/27/2010
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207RH0003X
License Number:
MD.31349
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Hydration infusion into a vein 31 minutes to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, dexamethasone sodium phosphate, 1 mg
Injection, fosaprepitant, 1 mg
Injection, palonosetron hcl, 25 mcg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970861

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970863

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970865

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970867

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970869

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970871

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970873

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970881

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970875

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970877

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Additional Office Locations

1. Birmingham Hematology Oncology Assoc Llc
2728 10th S Ave
Birmingham, AL 35205
Suite 200
Group Members: 28

Phone: 205-481-4511

Enter a starting address:

Medical Oncology Professionals in Bessemer

1.
Katisha Vance MD

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

2.
John Piede

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

3.
Christopher Wang

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

4.
Stephen Beck

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

5.
Shaily Lakhanpal

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

6.
Benjamin Jones

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

Providers in Birmingham Hematology Oncology Assoc Llc

1.Brian Adler Md

2022 Brookwood Med Ctr
Birmingham Al 35213-1966
Birmingham Hematology Oncology Assoc Llc
Hematology/oncology

2.Daniel Allendorf

1024 1st St N
Alabaster Al 35007-8703
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

3.Stephen Beck

737 Memorial Dr
Bessemer Al 35022-6029
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

4.Stephen Beck

2728 10th S Ave
Birmingham Al 35205-1202
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

5.Stephen Beck

810 Saint Vincents Dr
Birmingham Al 35205-1601
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

6.Cara Bondly Md

737 Memorial Dr
Bessemer Al 35022-6029
Birmingham Hematology Oncology Assoc Llc
Hematology/oncology

View all 28 members of Birmingham Hematology Oncology Assoc Llc medical group